Apable, Joaressa Fe S.

HRN: 22-25-99  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/05/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/05/2022
12/11/2022
IVT
600mg Ivt
Q6 X 7 Days
Fracture Prophylaxis, Skin Abrasions
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: